{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06227585",
            "orgStudyIdInfo": {
                "id": "ALM-488-003"
            },
            "organization": {
                "fullName": "Alume Biosciences, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Feasibility Study- REVEAL 475 for Bevonescein-Assisted Nerve Visualization in Head & Neck Surgery",
            "officialTitle": "Feasibility Study- REVEAL 475 System for Bevonescein-Assisted Intra-Operative Visualization of Nerves in Head and Neck Surgery",
            "therapeuticArea": [
                "Other"
            ],
            "study": "feasibility-study-reveal-for-bevonescein-assisted-nerve-visualization-in-head-neck-surgery"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-01",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-11-29",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-06",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-06",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-11-16",
            "studyFirstSubmitQcDate": "2024-01-18",
            "studyFirstPostDateStruct": {
                "date": "2024-01-29",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-01-30",
            "lastUpdatePostDateStruct": {
                "date": "2024-02-01",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Alume Biosciences, Inc.",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "Ergomed",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": true
        },
        "descriptionModule": {
            "briefSummary": "A feasibility study to evaluate the usability of the REVEAL 475 system in patients treated with bevonescein for nerve visualization during surgery.",
            "detailedDescription": "The REVEAL 475 system will be evaluated for its ability to visualize nerve-fluorescence following bevonescein administration. All patients will receive a single dose of bevonescein 500 mg via IV infusion 1-5 hours before undergoing parotidectomy, thyroidectomy or neck dissection surgery."
        },
        "conditionsModule": {
            "conditions": [
                "Head and Neck Surgery"
            ],
            "keywords": [
                "parotidectomy",
                "thyroidectomy",
                "neck dissection",
                "ALM-488",
                "bevonescein",
                "nerve",
                "fluorescence",
                "head and neck surgery",
                "intra-operative",
                "real-time",
                "REVEAL 475"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 80,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Single Arm (Bevonescein)",
                    "type": "EXPERIMENTAL",
                    "description": "All patients will receive a single administration of bevonescein 500mg via IV infusion and the REVEAL 475 system will be used on all patients.",
                    "interventionNames": [
                        "Device: REVEAL 475 System",
                        "Drug: Bevonescein"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "REVEAL 475 System",
                    "description": "The REVEAL 475 system will be evaluated for its ability to visualize nerve-fluorescence following bevonescein administration.",
                    "armGroupLabels": [
                        "Single Arm (Bevonescein)"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Bevonescein",
                    "description": "All patients will receive a single dose of bevonescein 500 mg via IV infusion 1-5 hours before surgery.",
                    "armGroupLabels": [
                        "Single Arm (Bevonescein)"
                    ],
                    "otherNames": [
                        "ALM-488"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Surgeon perspective on REVEAL 475 system blue light illumination",
                    "description": "Surgeon to provide responses to questions on a Likert scale 1-5 where a higher score means a better outcome",
                    "timeFrame": "Immediately after surgery"
                },
                {
                    "measure": "Surgeon perspective on REVEAL 475 system ease of use",
                    "description": "Surgeon to provide responses to questions on a Likert scale 1-5 where a higher score means a better outcome",
                    "timeFrame": "Immediately after surgery"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Plasma concentration of bevonescein",
                    "description": "Measurement of the concentration of bevonescein in plasma from all patients immediately before, during and immediately after surgery.",
                    "timeFrame": "1.5-5 hours before surgery, during surgery, and 0-12 hours after surgery"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Minimum of 16 years of age.\n* Planning to undergo surgery in the Head and Neck.\n* Study participant's primary surgical treatment is parotidectomy or thyroidectomy (unilateral or bilateral) or cervical neck dissection.\n* Willing and able to provide written assent as required and written informed consent by a legally authorized representative after the nature of the study has been explained, and prior to any research-related procedures.\n* Sexually active patients must be willing to use an acceptable method of contraception while participating in the study and for 30 days after receiving bevonescein.\n* Females of childbearing potential must have a negative pregnancy test at screening and be willing to have additional pregnancy tests during the study.\n\nExclusion Criteria:\n\n* Patient has a history of prior surgery and/or radiation to the intended surgical site.\n* Patient has abnormal cardiac rhythm not controlled with medication.\n* Patient has moderate to severe renal impairment as indicated by a glomerular filtration rate (GFR) \\< 60 mL/min.\n* Patient has decreased hepatic function defined as AST/SGOT and ALT/SGPT that is higher than 20% of the institution's normal laboratory limits, and/or the patient has elevated total bilirubin that is higher than 20% of the institution's normal laboratory limits.\n* Patient has unresolved acute toxicity from prior anti-cancer therapy, alopecia, neuropathy \\<= Grade 2, as well as other non-acute and stable anti-cancer therapy toxicities are acceptable.\n* Patient has a history of fluorescein allergy.\n* Patient has a history of drug-related anaphylactic or severe allergic reactions.\n* Presense or history of any hypersensitivity to bevonescein or its excipients that, in the judgment of the Investigator, places the patient at increased risk for adverse effects.\n* Presence of a concurrent disease or condition that may interfere with study participation including recent (within 6 months of screening) NYHA Class III or IV heart failure, myocardial infarction, or cerebrovascular accident.\n* Presence or history of any condition, that in the view of the Investigator, places the patient at high risk of poor treatment compliance or of not completing the study.\n* Pregnant or breastfeeding at screening or planning to become pregnant (self or partner) at any time during the study.\n* Use of any investigational product or investigational medical device within 30 days prior to screening, or requirement for any investigational agent prior to completion of all scheduled study assessments.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "16 Years",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Brett Berman, MD",
                    "role": "CONTACT",
                    "phone": "858-922-3977",
                    "email": "brett.berman@alumebiosciences.com"
                },
                {
                    "name": "Kim Potter",
                    "role": "CONTACT",
                    "phone": "706-338-1158",
                    "email": "kim.potter@alumebiosciences.com"
                }
            ],
            "locations": [
                {
                    "facility": "Jacobs Medical Center at UC San Diego Health",
                    "status": "RECRUITING",
                    "city": "San Diego",
                    "state": "California",
                    "zip": "92093",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Michael Bouvet, MD",
                            "role": "CONTACT",
                            "phone": "858-246-2223",
                            "email": "mbouvet@health.ucsd.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.71533,
                        "lon": -117.15726
                    }
                },
                {
                    "facility": "Harvard-Mass Eye & Ear",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Gregory Randolph, MD",
                            "role": "CONTACT",
                            "phone": "617-523-7900",
                            "email": "Gregory_Randolph@meei.harvard.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Henry Ford Health System",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Detroit",
                    "state": "Michigan",
                    "zip": "48202",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Michael Singer, MD",
                            "role": "CONTACT",
                            "phone": "586-263-2269",
                            "email": "msinger1@hfhs.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.33143,
                        "lon": -83.04575
                    }
                },
                {
                    "facility": "University of New Mexico",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Albuquerque",
                    "state": "New Mexico",
                    "zip": "87131",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ryan Orosoco, MD",
                            "role": "CONTACT"
                        },
                        {
                            "role": "CONTACT",
                            "phone": "505-272-2111",
                            "email": "RKOrosco@salud.unm.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.08449,
                        "lon": -106.65114
                    }
                },
                {
                    "facility": "University of Pennsylvania",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Karthik Rajasekaran, MD",
                            "role": "CONTACT",
                            "phone": "215-829-5180",
                            "email": "Karthik.Rajasekaran@pennmedicine.upenn.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "Thomas Jefferson University",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19107",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Joseph Curry, MD",
                            "role": "CONTACT",
                            "email": "joseph.curry@jefferson.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "MUSC- Hollings Cancer Center",
                    "status": "RECRUITING",
                    "city": "Charleston",
                    "state": "South Carolina",
                    "zip": "29425",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jason Newman, MD",
                            "role": "CONTACT",
                            "phone": "843-792-9300",
                            "email": "newmajas@musc.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.77657,
                        "lon": -79.93092
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        }
    },
    "hasResults": false
}